Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Mar. 31, 2025
ASSETS
Cash and cash equivalents	$ 6,808	$ 10,769
Restricted cash and cash equivalents	2,428	2,490
Investments in marketable securities	5,056	4,581
Finance receivables, net of allowance for credit losses of $1,476 and $1,644, respectively	101,192	101,749
Investments in operating leases, net	31,051	30,090
Other assets	6,342	5,615
Total assets	152,877	155,294
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	122,278	127,745
Deferred income taxes	3,638	2,973
Other liabilities	7,812	7,333
Total liabilities	133,728	138,051
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at December 31, 2025 and March 31, 2025	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(46)	(56)
Retained earnings	18,278	16,382
Total shareholder's equity	19,149	17,243
Total liabilities and shareholder's equity	$ 152,877	$ 155,294